Literature DB >> 30583806

Natural killer cells in sepsis: Underprivileged innate immune cells.

Vijay Kumar1.   

Abstract

Sepsis is a devastating health condition originating due to the dysregulated immune response in response to the severe systemic infection. The innate immune system serves as the first line of defense against invading pathogens, and the failure to clear the infection leads to the development of sepsis via generation of a proinflammatory immune response. Natural Killer (NK) cells are highly recognized potent innate immune cells that play a very important role in the generation of an antiviral and antitumor immune response. These are also unique innate immune cells due to the existence of NK cell-mediated memory due to the process of education and learning as shown by the cells of adaptive immunity. However, developing data has shown the importance of NK cells in mounting a potent immune response against invading bacterial pathogens that if not contained accordingly may lead to the development of sepsis. Thus, the present review article is designed to highlight the previously unrecognized function of NK cells during sepsis as indicated by both clinical and experimental animal-based findings. However, a brief introduction regarding their development, subtypes, and function is also mentioned before describing their role in sepsis. Thereafter, the subsequent section is included describing the NK cell immunometabolic reprogramming during homeostasis, infection, and sepsis. NK cell immune memory and their therapeutic targeting to manage the sepsis as a future therapeutic approach emphasized before closing the manuscript.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  IFN-γ; Immunometabolism; NK cells; Sepsis; Septic shock; Severe sepsis

Mesh:

Year:  2018        PMID: 30583806     DOI: 10.1016/j.ejcb.2018.12.003

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  7 in total

Review 1.  Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.

Authors:  Ren-Qi Yao; Chao Ren; Li-Yu Zheng; Zhao-Fan Xia; Yong-Ming Yao
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

Review 2.  Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment.

Authors:  Arefeh Basiri; Fatemeh Mansouri; Arezo Azari; Parviz Ranjbarvan; Fateme Zarein; Arash Heidari; Ali Golchin
Journal:  Stem Cell Rev Rep       Date:  2021-01-28       Impact factor: 5.739

Review 3.  Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis.

Authors:  Chao Cao; Muming Yu; Yanfen Chai
Journal:  Cell Death Dis       Date:  2019-10-14       Impact factor: 8.469

4.  Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome.

Authors:  Dong Ling Tong; Karen E Kempsell; Tamas Szakmany; Graham Ball
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

5.  Natural killer cell deficiency experiences higher risk of sepsis after critical intracerebral hemorrhage.

Authors:  Yu Feng; Qian Wu; Tingbao Zhang; Jincao Chen; Xiaohui Wu
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 6.  Immune Intervention in Sepsis.

Authors:  Jian Chen; Haiming Wei
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

Review 7.  The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines.

Authors:  Juan Huang; Zhiyao Long; Renyong Jia; Mingshu Wang; Dekang Zhu; Mafeng Liu; Shun Chen; Xinxin Zhao; Qiao Yang; Ying Wu; Shaqiu Zhang; Bin Tian; Sai Mao; Xumin Ou; Di Sun; Qun Gao; Anchun Cheng
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.